Advanced Medical Solutions Group Plc · LSE:AMS
Advanced Medical Solutions — Shareholder Meeting (June 2024)
5 slides from Advanced Medical Solutions's shareholder meeting presentation, Jun 12, 2024
Slide 1: Annual General Meeting – Chris Meredith (CEO)
Advanced Medical Solutions Annual General Meeting – Chris Meredith (CEO) 12th June 2024 11
Slide 2: FY 2023 Financial Highlights
FY 2023 Financial Highlights • Revenues increased by 2% to £126.2 million (2022: 124.3 million) • R&D spend increased to £12.5 million (2022: £12.3 million) reflecting ongoing investment in innovation and MDR • Adjusted pre-tax profit reduced to £25.9 million (2022: £28.5 million) as margins were im
Slide 3: FY 2023 Highlights
FY 2023 Highlights Key initiatives set to drive strong growth • Acquisition of Connexicon Ltd in February 2023 increasing our ability to develop and commercialise innovative and differentiated adhesive and sealant technologies • Successful implementation of new US LiquiBand® route to market strategy
Slide 4: Peters Surgical Acquisition – completion expected Q3 2024
Peters Surgical Acquisition – completion expected Q3 2024 Meets all of AMS’s strategic criteria for acquisitions: Expand presence in operating room Increase portfolio of “own” brand products Increase direct sales force capabilities Peters Surgical focussed entirely on surgical Peters Surgical “o
Slide 5: Summary and Outlook
Summary and Outlook Stronger platform established to raise growth profile from 2024 • New US LiquiBand® route to market strategy positively impacting performance • US launch of LIQUIFIXTM progressing well with orders ahead of expectations • Syntacoll acquisition significantly strengthens Biosurgical
Advanced Medical Solutions Group — Shareholder Meeting (June 2024) on 6ix